Pictet Asset Management’s AbbVie ABBV Stock Holding History

Pictet Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255M	Buy	1,173,729 +25,003	+2%	+$5.55M	0.27%	99
2025 Q4	$262M	Buy	1,148,726 +105,458	+10%	+$24M	0.25%	93
2025 Q3	$241M	Buy	1,043,268 +4,787	+0.5%	+$975K	0.23%	110
2025 Q2	$193M	Buy	1,038,481 +162,906	+19%	+$30.3M	0.2%	124
2025 Q1	$183M	Buy	875,575 +58,186	+7%	+$11.3M	0.2%	125
2024 Q4	$145M	Buy	817,389 +26,771	+3%	+$4.92M	0.16%	156
2024 Q3	$156M	Sell	790,618 -2,612	-0.3%	-$487K	0.17%	154
2024 Q2	$136M	Sell	793,230 -63,786	-7%	-$10.6M	0.16%	160
2024 Q1	$156M	Sell	857,016 -91,173	-10%	-$15.7M	0.17%	154
2023 Q4	$147M	Buy	948,189 +31,430	+3%	+$4.58M	0.16%	158
2023 Q3	$137M	Buy	+916,759	New	+$135M	0.17%	160

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pictet Asset Management's ABBV Position: Q1 2026 in Review

Pictet Asset Management increased its AbbVie (ABBV) stake by 2.2% in Q1 2026, buying an estimated $5.55M and bringing the position to 1,173,729 shares worth $255M. The position accounts for 0.27% of the portfolio, ranked #99.

Pictet Asset Management first reported a position in ABBV in Q3 2023 and has held it in 11 quarters since. The position peaked at $262M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Pictet Asset Management held 1,173,729 shares of AbbVie worth $255M as of Q1 2026.
Pictet Asset Management bought 25,003 AbbVie shares in Q1 2026, an estimated $5.55M.
AbbVie made up 0.27% of Pictet Asset Management's portfolio in Q1 2026, its #99 holding.
Pictet Asset Management first reported a position in AbbVie in Q3 2023 and has held it in 11 quarters since.
Pictet Asset Management's AbbVie position peaked at $262M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.